Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

This study has been completed.
Information provided by:
Canadian Cancer Trials Group Identifier:
First received: November 1, 1999
Last updated: November 7, 2010
Last verified: November 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Estimated Primary Completion Date: No date given